Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008

dc.creatorPerdomo A., Iván A.
dc.creatorNieto, Víctor Hugo
dc.creatorMejía, Rossana
dc.creatorRuiz, Oscar
dc.date.accessioned2009-09-01 00:00:00
dc.date.accessioned2022-02-21T20:37:32Z
dc.date.accessioned2022-09-27T12:45:24Z
dc.date.available2009-09-01 00:00:00
dc.date.available2022-02-21T20:37:32Z
dc.date.available2022-09-27T12:45:24Z
dc.date.created2009-09-01 00:00:00
dc.date.created2022-02-21T20:37:32Z
dc.date.issued2009-09-01
dc.identifier10.31260/RepertMedCir.v18.n3.2009.546
dc.identifier0121-7372
dc.identifierhttps://repositorio.fucsalud.edu.co/handle/001/2440
dc.identifier2462-991X
dc.identifierhttps://doi.org/10.31260/RepertMedCir.v18.n3.2009.546
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3597116
dc.languagespa
dc.publisherSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.relationDucoulombier V, Solau E, Coquerelle P. Long – term results of Infliximab therapy in rheumatoid arthritis: Experience acquired by the North-Pas-de-Calais hospital network . Joint Bone Spine. 2007 Jan;74(1):56-9
dc.relationLipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000 Nov 30;343(22):1594-602.
dc.relationGodinho F, Godfrin B. Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheumatol. 2004 May-Jun; 22(3):328-30.
dc.relationWilliams RO. Pathogenesis and therapy of rheumatoid arthritis. Ernst Schering Found Symp Proc. 2006; 1:107-30.
dc.relationAsociación Colombiana de Reumatología. Grupo de Expertos. Primer consenso colombiano sobre el tratamiento de la artritis reumatoide temprana. Rev. Colomb.Reumatol. 2002 diciembre; 9(4): 323-31.
dc.relationSimon LS. The treatment of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2004 Aug;18(4):507-38
dc.relationStrady C, Brochot P, Ainine K, Jegou J, Remy G, Eschard JP, Jaussaud R. [Tuberculosis during treatment by TNFalpha-inhibitors]. Presse Med. 2006 Nov; 35(11 Pt 2):1765-72.
dc.relationCurtis JR, Patkar N, Xie A, Martin C, Allison JJ, Saag M, Shatin D, Saag KG. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumour necrosis factor alpha antagonists. Arthritis Rheum. 2007 Apr; 56(4):1125-33.
dc.relationGodinho F, Godfrin B, El Mahou S, Navaux F, Zabraniecki L, Cantagrel A. Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheumatol. 2004 May-Jun; 22(3):328-30.
dc.relationCunnane G, Doran M, Bresnihan B. Infections and biological therapy in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2003 Apr;17(2):345-63.
dc.relationSiddiqui MA. The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence. Curr Opin Rheumatol. 2007 19 (3): 308-13.
dc.relationAskling J, Dixon W. The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis Curr Opin Rheumatol. 2008 Mar; 20(2):138-44.
dc.relationCase JP. Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective Part 1: The Older Drugs American Journal of Therapeutics 2001 8, 123–143.
dc.relationJohn P. Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs. Am J Ther. 2001 Mar-Apr; 8(2):123-43.
dc.relationSchneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007 Jun; 56(6):1754-64.
dc.relationBuch MH, Bingham SJ, Bryer D, Emery P. Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders. Rheumatology (Oxford). 2007 Jul; 46(7):1153-6.
dc.relationBrassard P, Kezouh A, Suissa S. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis. 2006 Sep 15; 43(6):717-22.
dc.relationMaillard H, Ornetti P, Grimault L, Ramon JF, Ducamp SM, Saidani T, Tavernier C, Maillefert JF. Severe pyogenic infections in patients taking infliximab: a regional cohort study. Joint Bone Spine. 2005 Jul; 72(4):330-4.
dc.relationFuentealba C. ¿Cómo se debe evaluar al paciente con artritis reumatoide en la práctica clínica?. Reumatología. 2003; 19(4):190-93.
dc.relationhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/546/586
dc.relationNúm. 3 , Año 2009 : Julio - Septiembre
dc.relation151
dc.relation3
dc.relation144
dc.relation18
dc.relationRevista Repertorio de Medicina y Cirugía
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightsFundación Universitaria de Ciencias de la Salud FUCS - 0
dc.sourcehttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/546
dc.subjectartritis reumatoidea
dc.subjectterapia biológica
dc.subjectinfliximab
dc.subjectfactores de necrosis tumoral
dc.subjectrheumatoid arthritis
dc.subjectbiological therapy
dc.subjectinfliximab
dc.subjecttumor necrosis factors
dc.titleDesenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008
dc.typeArtículo de revista
dc.typeJournal article


Este ítem pertenece a la siguiente institución